AAAAAA

   
Results: 1-25 | 26-30 |
Results: 26-30/30
ARE LOW-DOSES OF FLOSEQUINAN EFFECTIVE IN CHRONIC HEART-FAILURE
Authors: KUKIN ML KESSLER PD NEUBERG GD DESSANTI M WEINBERG M MEDINA N YUSHAK M GOTTLIEB S
Citation: Ml. Kukin et al., ARE LOW-DOSES OF FLOSEQUINAN EFFECTIVE IN CHRONIC HEART-FAILURE, Circulation, 88(4), 1993, pp. 47-47
BETA-BLOCKADE AS A BRIDGE TO CARDIAC TRANSPLANT
Authors: KALMAN J BUCHHOLZ C STEINMETZ M COURTNEY M DESSANTI M GASS A LANSMAN S KUKIN ML
Citation: J. Kalman et al., BETA-BLOCKADE AS A BRIDGE TO CARDIAC TRANSPLANT, Circulation, 88(4), 1993, pp. 93-93
DO BETA-BLOCKERS RETAIN AN ACUTE NEGATIVE INOTROPIC EFFECT DESPITE CHRONIC BETA-BLOCKADE IN PATIENTS WITH HEART-FAILURE
Authors: KUKIN ML KALMAN J GASS A LOTVIN A BUCHHOLZ C
Citation: Ml. Kukin et al., DO BETA-BLOCKERS RETAIN AN ACUTE NEGATIVE INOTROPIC EFFECT DESPITE CHRONIC BETA-BLOCKADE IN PATIENTS WITH HEART-FAILURE, Circulation, 88(4), 1993, pp. 104-104
DOES COMBINED ALPHA AND BETA-BLOCKADE ENHANCE HEMODYNAMIC BENEFITS BEYOND BETA-BLOCKADE ALONE IN CONGESTIVE-HEART-FAILURE
Authors: KALMAN J BUCHHOLZ C CHOCKALINGAM S KUKIN ML
Citation: J. Kalman et al., DOES COMBINED ALPHA AND BETA-BLOCKADE ENHANCE HEMODYNAMIC BENEFITS BEYOND BETA-BLOCKADE ALONE IN CONGESTIVE-HEART-FAILURE, Circulation, 88(4), 1993, pp. 104-104
CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET)
Authors: MASSIE BM BERK MR BROZENA SC ELKAYAM U PLEHN JF KUKIN ML PACKER M MURPHY BE NEUBERG GW STEINGART RM LEVINE TB DEHAAN H
Citation: Bm. Massie et al., CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET), Circulation, 88(2), 1993, pp. 492-501
Risultati: 1-25 | 26-30 |